Neural Cell News Volume 15.00 | Jan 6 2021

    0
    158








    2021-01-06 | NCN 15.00


    Neural Cell News by STEMCELL Technologies
    Vol. 15.00 – 6 January, 2021
    TOP STORY

    Gut-Licensed IFNγ+ NK Cells Drive LAMP1+TRAIL+ Anti-Inflammatory Astrocytes

    Using high-throughput flow cytometry screening, single-cell RNA sequencing, and CRISPR–Cas9-based cell-specific in vivo genetic perturbations in mice, the authors identified a subset of astrocytes that expressed the lysosomal protein LAMP12 and the death receptor ligand TRAIL.
    [Nature]

    Abstract

    Explore scientific events this January with the Science Events Calendar.
    PUBLICATIONSRanked by the impact factor of the journal

    Sequential Fate-Switches in Stem-Like Cells Drive the Tumorigenic Trajectory from Human Neural Stem Cells to Malignant Glioma

    Researchers established two highly penetrant human neural stem cell-derived malignant glioma models, which resembled the histopathology and transcriptional heterogeneity of human glioblastoma.
    [Cell Research]

    Full Article

    Trisomy 21–Induced Dysregulation of Microglial Homeostasis in Alzheimer’s Brains Is Mediated by USP25

    Investigators showed that triplication of homologous chromosome 21 genes aggravated neuroinflammation in combined murine Down syndrome-Alzheimer’s disease models.
    [Science Advances]

    Full Article

    BBB Pathophysiology–Independent Delivery of siRNA in Traumatic Brain Injury

    The authors report a nanoparticle platform for blood-brain barrier (BBB) pathophysiology–independent delivery of small interfering RNA (siRNA) in traumatic brain injury.
    [Science Advances]

    Full Article

    Filamentous Recombinant Human Tau Activates Primary Astrocytes via an Integrin Receptor Complex

    Investigators showed that integrin αV/β1 receptor bound recombinant human Tau, mediating the entry of Tau fibrils in astrocytes.
    [Nature Communications]

    Full Article

    Transcriptional and Morphological Profiling of Parvalbumin Interneuron Subpopulations in the Mouse Hippocampus

    Scientists used single-cell RNA-seq in morphologically identified parvalbumin interneurons and studied their transcriptomic states in the morphological, physiological, and developmental domains.
    [Nature Communications]

    Full Article

    TDP-43 Aggregation Induced by Oxidative Stress Causes Global Mitochondrial Imbalance in ALS

    Investigators report that TDP-43 aggregation in neuronal cells of mouse and human origin caused sensitivity to oxidative stress.
    [Nature Structural & Molecular Biology]

    Abstract

    Cross-Comparison of Human iPSC Motor Neuron Models of Familial and Sporadic ALS Reveals Early and Convergent Transcriptomic Disease Signatures

    By repeatedly differentiating and applying single-cell RNA (scRNA-seq) to motor neurons from healthy, familial ALS, sporadic ALS, and genome-edited iPSC lines across multiple patients, batches, and platforms, scientists accounted for genetic and experimental variability toward identifying unified and reproducible ALS signatures.
    [Cell Systems]

    AbstractGraphical Abstract

    Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression

    Researchers report that Piwi-like family members were overexpressed in glioblastoma, with Piwil1 most frequently overexpressed. Piwil1 was enriched in glioma stem-like cells to maintain self-renewal.
    [Cell Reports]

    Full ArticleGraphical Abstract

    ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism

    The authors described a detrimental role of ApoE4 in regulating fatty acid (FA) metabolism across neurons and astrocytes in tandem with their distinctive mitochondrial phenotypes. ApoE4 disrupted neuronal function by decreasing FA sequestering in lipid droplets.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Oncogenic ZEB2/miR-637/HMGA1 Signaling Axis Targeting Vimentin Promotes the Malignant Phenotype of Glioma

    Scientists investigated the potential interaction between zinc finger E-box binding homeobox 2 (ZEB2) and microRNA-637 (miR-637) and its downstream signaling pathway in glioma. The results revealed that ZEB2 could directly bind to the E-box elements in the miR-637 promoter and promoted cell proliferation, migration, and invasion via miR-637 downregulation.
    [Molecular Therapy-Nucleic Acids]

    AbstractFull ArticleGraphical Abstract

    Plasma-Borne Indicators of Inflammasome Activity in Parkinson’s Disease Patients

    Researchers evaluated Parkinson’s disease patient plasma for evidence of inflammasome activity. Multiple circulating inflammasome proteins were detected almost exclusively in extracellular vesicles indicative of ongoing inflammasome activation and pyroptosis.
    [npj Parkinson’s Disease]

    Full Article

    He knew neuronal cultures should be active. So he invented a new medium. Watch Cedric Bardy's webinar.
    REVIEWS

    The Two-Cell Model of Glucose Metabolism: A Hypothesis of Schizophrenia

    Investigators developed a ‘two-cell’ model of glucose metabolism, which can explain the effects of electroconvulsive therapy and the beneficial and side effects of olanzapine treatment.
    [Molecular Psychiatry]

    Full Article

    INDUSTRY AND POLICY NEWS

    Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis

    Passage Bio, Inc. announced that the FDA has cleared an investigational new drug (IND) application for the company’s lead product candidate, PBGM01, an adeno-associated virus-delivery gene therapy that is being studied for the treatment of infantile GM1 gangliosidosis.
    [Passage Bio, Inc.]

    Press Release

    BioXcel Therapeutics Announces BXCL501 Met the Primary and All Secondary Endpoints in the TRANQUILITY Phase Ib/II Study for the Acute Treatment of Agitation in Dementia, including Alzheimer’s Disease

    BioXcel Therapeutics, Inc. announced that BXCL501, the company’s proprietary, orally dissolving thin film formulation of dexmedetomidine, met the primary and secondary endpoints of the TRANQUILITY trial at the 60 mcg dose level.
    [BioXcel Therapeutics, Inc.]

    Press Release

    FEATURED EVENT

    Cambridge Cancer Epigenetics Club: Polycomb Repressive Complex 2 and Its Roles in Stem Cells and Cancer

    January 8, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Nervous System

    German Center for Neurodegenerative Diseases – Bonn, Germany

    Research & Development Specialist – Molecular and Functional Neurobiology

    University of Luxembourg – Belval, Luxembourg

    Postdoctoral Researcher – Molecular and Functional Neurobiology

    University of Luxembourg – Belval, Luxembourg

    Research Associate – Neurobiology

    University of Virginia – Charlottesville, Virginia, United State

    Tenure Track Position – Laboratory or Clinical Neuroscience

    UT Southwestern Medical Center – Dallas, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Neural Cell News Archives Contact Us
    Neural Cell News Twitter